A01N63/40

<i>Pseudomonas aeruginosa </i>bacteriophage Pse-AEP-3 and use thereof for inhibiting proliferation of <i>Pseudomonas aeruginosa</i>

The present invention relates to Podoviridae bacteriophage Pse-AEP-3 (accession number: KCTC 13165BP) isolated from nature, the Podoviridae bacteriophage Pse-AEP-3 having the capability to specifically kill Pseudomonas aeruginosa and having a genome represented by SEQ ID NO: 1, and a method for preventing or treating diseases induced by Pseudomonas aeruginosa by using a composition containing the Podoviridae bacteriophage Pse-AEP-3 as an active ingredient.

CONTROL OF GREEN MACROALGAE BLOOMS
20220279796 · 2022-09-08 · ·

The control of green macroalgae blooms. More particularly, Ulva algae blooms may be controlled by a living active principle contained in seawater from the Mediterranean Sea. The inventors have observed that seawater from the Mediterranean Sea collected in particular spots (collected at, e.g., latitude 43° 14′N and longitude 5° 21′E, or at latitude 43° 09′N and longitude 5° 36′E) is capable of promoting the death of Ulva lactuca, without the emission of toxic acidic vapors, such as, e.g., H.sub.2S vapors. Altogether, the inventors provide data showing that this seawater comprises an alive microorganism that is responsible for promoting the death of Ulva, in particular of Ulva lactuca. More precisely, the inventors provide experimental data showing that the microorganism that promotes the death of Ulva lactuca, and hence promotes the control of Ulva lactuca blooms, is a virus.

CONTROL OF GREEN MACROALGAE BLOOMS
20220279796 · 2022-09-08 · ·

The control of green macroalgae blooms. More particularly, Ulva algae blooms may be controlled by a living active principle contained in seawater from the Mediterranean Sea. The inventors have observed that seawater from the Mediterranean Sea collected in particular spots (collected at, e.g., latitude 43° 14′N and longitude 5° 21′E, or at latitude 43° 09′N and longitude 5° 36′E) is capable of promoting the death of Ulva lactuca, without the emission of toxic acidic vapors, such as, e.g., H.sub.2S vapors. Altogether, the inventors provide data showing that this seawater comprises an alive microorganism that is responsible for promoting the death of Ulva, in particular of Ulva lactuca. More precisely, the inventors provide experimental data showing that the microorganism that promotes the death of Ulva lactuca, and hence promotes the control of Ulva lactuca blooms, is a virus.

Genetically Engineered Bacteriophage
20220259570 · 2022-08-18 ·

A method of engineering bacteriophages comprising isolating a bacteriophage; removing all attachment genes from a genome of said bacteriophage; inserting a first unique open reading frame encoding one or more attachment genes and inserting a second unique open reading frame encoding one or more genes useful for overcoming bacterial defenses; and inserting a non-natural attachment gene into said first open reading frame, wherein said non-natural attachment gene is specific for attaching to a selected bacteria.

COMPOSITIONS AND METHODS FOR COATING OF NITRIFICATION INHIBITORS WITH A SOLUTION CONTAINING A HIGH CONCENTRATION OF UREASE INHIBITORS

A dry, flowable additive composition for combination with a fertilizer that increases longevity of plant available nitrogen from the fertilizer while in the soil.

COMPOSITIONS AND METHODS FOR COATING OF NITRIFICATION INHIBITORS WITH A SOLUTION CONTAINING A HIGH CONCENTRATION OF UREASE INHIBITORS

A dry, flowable additive composition for combination with a fertilizer that increases longevity of plant available nitrogen from the fertilizer while in the soil.

<i>Escherichia coli </i>bacteriophage Esc-COP-7, and use thereof for suppressing proliferation of pathogenic <i>Escherichia coli</i>

The present invention relates to a Myoviridae bacteriophage ESC-COP-7 (accession number KCTC 13130BP) isolated from nature, and a method for preventing and treating infections from pathogenic Escherichia coli by means of a composition containing the Myoviridae bacteriophage ESC-COP-7 as an active ingredient, the Myoviridae bacteriophage ESC-COP-7 being characterized by having the capability to specifically kill Escherichia coli, and genome expressed by the SEQ ID 1.

<i>Escherichia coli </i>bacteriophage Esc-COP-7, and use thereof for suppressing proliferation of pathogenic <i>Escherichia coli</i>

The present invention relates to a Myoviridae bacteriophage ESC-COP-7 (accession number KCTC 13130BP) isolated from nature, and a method for preventing and treating infections from pathogenic Escherichia coli by means of a composition containing the Myoviridae bacteriophage ESC-COP-7 as an active ingredient, the Myoviridae bacteriophage ESC-COP-7 being characterized by having the capability to specifically kill Escherichia coli, and genome expressed by the SEQ ID 1.

FIBROUS STRUCTURES COMPRISING A SURFACE CARE COMPOSITION AND METHODS FOR MAKING AND USING SAME

Fibrous structures containing a surface care composition, and more particularly dry fibrous structures containing a surface care composition comprising one or more bacteriophage, methods of making same, and methods for treating surfaces using same are provided.

FIBROUS STRUCTURES COMPRISING A SURFACE CARE COMPOSITION AND METHODS FOR MAKING AND USING SAME

Fibrous structures containing a surface care composition, and more particularly dry fibrous structures containing a surface care composition comprising one or more bacteriophage, methods of making same, and methods for treating surfaces using same are provided.